NASDAQ:VSEE • US92919Y1029
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VSEE HEALTH INC (VSEE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-02-24 | Maxim Group | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.766M | 10.421M 80.74% | 16.954M 62.68% | 22.045M 30.03% | ||
| EBITDA YoY % growth | N/A | -1.786M | -3.359M -88.08% | -4.037M -20.18% | -2.237M 44.59% | |
| EBIT YoY % growth | -3.59M -1,182.14% | -1.787M 50.23% | -4.683M -162.08% | -6.485M -38.49% | -5.093M 21.47% | |
| Operating Margin | N/A | -30.99% | -44.93% | -38.25% | -23.10% | |
| EPS YoY % growth | N/A | N/A | N/A | -0.37 -1,100.00% | -0.24 33.33% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
7 analysts have analysed VSEE and the average price target is 5.1 USD. This implies a price increase of 1658.62% is expected in the next year compared to the current price of 0.29.
The number of analysts covering VSEE HEALTH INC (VSEE) is 7.